Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (Diluted Average) (2019 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 60.95% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, up 60.95% year-over-year, with the annual reading at $2.4 million for FY2025, 60.95% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $2.4 million at Creative Medical Technology Holdings, down from $2.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $1.2 billion in Q1 2021, with the low at $1.4 million in Q3 2024.
  • Average Shares Outstanding (Diluted Average) over 5 years is $163.5 million, with a median of $2.4 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 588.37% in 2021, then plummeted 87.12% in 2023.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $3.2 million in 2021, then soared by 236.51% to $10.9 million in 2022, then tumbled by 87.12% to $1.4 million in 2023, then rose by 5.17% to $1.5 million in 2024, then soared by 60.95% to $2.4 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $2.4 million, $2.6 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.